Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 20 2023 - 9:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
Dated June 19, 2023
Commission File Number 001-38018
Integrated Media Technology Limited
(Exact Name as Specified in its Charter)
N/A
(Translation of Registrant’s Name)
Suite 1401 Level 14, 219-227 Elizabeth Street
Sydney NSW 2000 Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Board of Directors and Officers –
Changes to Membership
Resignation of a Director and
CFO
Ms. Jing ZHUO
The board of directors (the “Board”)
of Integrated Media Technology Limited (the “Company”) received the letter of resignation from Ms. Jing Zhuo (“Ms. Zhuo”),
as a director and Chief Financial Officer of the Company, with effect on June 19, 2023. Ms. Zhuo’s resignation was not as a result
of any disagreement with the Company relating to its operations, policies or practices.
The Board hereby extends its sincere appreciation
for the contribution of Ms. Zhuo to the Company.
Appointment of Director
Dr. Zhi-Cheng Xiao
Effective as of June 19, 2023, the Board appointed
Dr. Zhi-Cheng Xiao (“Dr. Xiao”), aged 66, as the independent member as well as a member of the Audit Committee and the Nomination
and Remuneration Committee. Dr. Xiao meets the Nasdaq Stock Market independence requirements as well as additional independence requirements
under U.S. securities laws for membership on the Audit Committee.
Dr. Xiao has since 2011 to now a Professor in
the Department of Anatomy and Developmental Biology at Monash University in Melbourne Australia. He has also worked with one the of the
world’s top pharmaceutical companies as a director of research in neuroscience and neurodegenerative diseases. Dr. Xiao has published
more than 130 papers in reputed journals and served as editorial board members of more than 10 journals. He has established IRP Health
and UPcare Group in Melbourne.
Dr. Xiao focus of research is the molecular events
that mediate communication among neural cells, in the nervous system during development, myelination, learning and memory, degeneration,
and regeneration. These studies have yielded insights into the therapeutic potential of cell signaling molecules to ameliorate or even
ablate the detrimental consequences of nervous system injury and neurodegenerative diseases, including stroke, traumatic brain injury,
spinal cord injury, Alzheimer Disease (AD), and Multiple Sclerosis (MS).
Dr. Xiao received his Doctor of Natural Science
Degree from the Swiss Federal Institute of Technology, Zurich. He received his undergraduate degree in Medicine from Harbin Medical University,
China. Dr. Xiao is also a member of the American Society of Biological Chemistry, American Society of Neuroscience, International Society
of Stem Cells, International Society of Alzheimer’s disease, and Australasian Neuroscience Society.
Dr. Xiao does not have a family relationship with
any other director or officer of the Company as defined in Item 401 of Regulation S-K.
Appointment of Interim CFO
Mohd Hazrol Bin MOHD ROSMEY
On June 19, 2023, the Board appointed Mr. Mohd
Hazrol Bin Mohd Rosmey (“Mr. Mohd Rosmey”) as interim Chief Financial Officer of the Company. Mr. Mohd Rosmey is currently
the Financial Controller of the Company’s operation in Malaysia and will be redesignated and assume the role as the interim Chief
Financial Officer of the Company. Mr. Mohd Rosmey has over 15 years of experience as Branch Manager in a local bank in Malaysia. Currently
he is the Financial Controller of the Company’s subsidiary operation in Malaysia. From 2012 to 2019, he was the Branch Manager to
AmBank (M) Berhad, responsible to manage branch operation and sales, staff under supervision and ensure branch operation comply with the
Standard operation Procedure (S.O.P) requirement. Prior to joining AmBank (M) Berhad, Mr. Mohd Rosmey has worked in Personal Financial
Consultant and Personal Banker in Hong Leong Bank Bhd.
Mr. Mohd Rosmey received a Bachelor of Business
Administration from University of Malaya.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: June 20, 2023
|
Integrated
Media Technology Limited |
|
|
|
|
By: |
/s/
Dr. Megat Radzman Bin Megat Khairuddin |
|
Name:
|
Dr.
Megat Radzman Bin Megat Khairuddin |
|
Title: |
Chief
Executive Officer |
2
Intergrated Media Techno... (NASDAQ:IMTE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Intergrated Media Techno... (NASDAQ:IMTE)
Historical Stock Chart
From Oct 2023 to Oct 2024